Chakraborty, P., and K. Chakraborty. “Anti-Fibrotic Agents Could Be the Game-Changer for Post-COVID-19 Pulmonary Fibrosis Treatment”. European Journal of Biological Research, Vol. 12, no. 1, Jan. 2022, pp. 1-10, https://journals.tmkarpinski.com/index.php/ejbr/article/view/519.